KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Total Debt (2016 - 2026)

Quest Diagnostics' Total Debt history spans 18 years, with the latest figure at $5.7 billion for Q1 2026.

  • On a quarterly basis, Total Debt fell 3.43% to $5.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $5.7 billion, a 3.43% decrease, with the full-year FY2025 number at $5.7 billion, down 8.78% from a year prior.
  • Total Debt hit $5.7 billion in Q1 2026 for Quest Diagnostics, roughly flat from $5.7 billion in the prior quarter.
  • Over the last five years, Total Debt for DGX hit a ceiling of $6.3 billion in Q3 2024 and a floor of $4.0 billion in Q1 2023.
  • Historically, Total Debt has averaged $4.9 billion across 5 years, with a median of $4.7 billion in 2024.
  • Biggest five-year swings in Total Debt: soared 47.08% in 2024 and later fell 9.21% in 2025.
  • Tracing DGX's Total Debt over 5 years: stood at $4.0 billion in 2022, then grew by 18.42% to $4.7 billion in 2023, then soared by 31.91% to $6.2 billion in 2024, then fell by 8.78% to $5.7 billion in 2025, then dropped by 0.23% to $5.7 billion in 2026.
  • Business Quant data shows Total Debt for DGX at $5.7 billion in Q1 2026, $5.7 billion in Q4 2025, and $5.7 billion in Q3 2025.